Document:

Exhibit 10.7

RSDL ENTERPRISES CONSULTING AGREEMENT

BioForce NanoSciences Holdings, Inc. desires to have services provided by Aldo Dalla-Vecchia of RSDL Enterprises.

 

Therefore, the parties agree as follows: 

 

1. DESCRIPTION OF SERVICES. 

Beginning on May 25, 2020, Aldo Dalla-Vecchia will provide the following services (collectively, the "Services"): 

General Consulting for Management 

2. PERFORMANCE OF SERVICES. 

The manner in which the Services are to be performed and the specific hours to be worked by Aldo Dalla-Vecchia shall be determined by Aldo Dalla-Vecchia. BioForce NanoSciences Holdings, Inc. will rely on Aldo Dalla-Vecchia to work as many hours as may be reasonably necessary to fulfill Aldo Dalla-Vecchia's obligations under this Agreement.

3. PAYMENT. 

BioForce NanoSciences Holdings, Inc. will pay a fee to Aldo Dalla-Vecchia for the Services in the amount of $7,000.00 (Seven Thousand Dollars). This fee shall be payable in a lump-sum upon within 48-hours upon signing agreement. 

4. NEW PROJECT APPROVAL. 

Aldo Dalla-Vecchia and BioForce NanoSciences Holdings, Inc. recognize that Aldo Dalla-Vecchia's Services will include working on various projects for BioForce NanoSciences Holdings, Inc. Aldo Dalla-Vecchia shall obtain the approval of BioForce NanoSciences Holdings, Inc. prior to the commencement of a new project. 

5. TERM/TERMINATION. 

This Agreement shall terminate automatically on July 27, 2020 at 5:30 PM ET. 

-1-

6. RELATIONSHIP OF PARTIES. 

It is understood by the parties that Aldo Dalla-Vecchia is an independent contractor with respect to BioForce NanoSciences Holdings, Inc., and not an employee of BioForce NanoSciences Holdings, Inc.

 

BioForce NanoSciences Holdings, Inc. will not provide fringe benefits, including health insurance benefits, paid vacation, or any other employee benefit, for the benefit of Aldo Dalla-Vecchia. 

 

7. INDEMNIFICATION. 

Aldo Dalla-Vecchia agrees to indemnify and hold harmless BioForce NanoSciences Holdings, Inc. from all claims, losses, expenses, fees including attorney fees, costs, and Judgments that may be asserted against BioForce NanoSciences Holdings, Inc. that result from the acts or omissions of Aldo Dalla-Vecchia, Aldo Dalla-Vecchia's employees, if any, and Aldo Dalla-Vecchia's agents. 

8. RETURN OF RECORDS. 

Upon termination of this Agreement, Aldo Dalla-Vecchia shall deliver all records, notes, data, memoranda, models, and equipment of any nature that are in Aldo Dalla-Vecchia's possession or under Aldo Dalla-Vecchia's control and that BioForce NanoSciences Holdings, Inc 's property or relate to BioForce NanoSciences Holdings, Inc.’s  business. 

 

9. NOTICES. 

All notices required or permitted under this Agreement shall be in writing and shall be deemed delivered when delivered in person or deposited in the United States mail, postage prepaid, addressed as follows: 

IF for BioForce NanoSciences Holdings, Inc.

BioForce NanoSciences Holdings, Inc.

Richard Kaiser, its Secretary 

2020 General Booth Blvd Suite 230 Virginia Beach, Virginia 23454 

IF for Aldo Dalla-Vecchia:

 RSDL Enterprises, 3700 Colchester Road Lansing, Michigan 48906

 Such address may be changed from time to time by either party by providing written notice to the other in the manner set forth above. 

10. ENTIRE AGREEMENT. 

This Agreement contains the entire agreement of the parties and there are no other promises or conditions in any other agreement whether oral or written. This Agreement supersedes any prior written or oral agreements between the parties. 

-2-

11. AMENDMENT. 

This Agreement may be modified or amended if the amendment is made in writing and is signed by both parties. 

12. SEVERABILITY. 

If any provision of this Agreement shall be held to be invalid or unenforceable for any reason, the remaining provisions shall continue to be valid and enforceable. If a court finds that any provision of this Agreement is
invalid or unenforceable, but that by limiting such provision it would become valid and  enforceable, then  such provision shall be deemed to be written, construed, and enforced as so limited. 

 

13. WAIVER OF CONTRACTUAL RIGHT. 

The failure of either party to enforce any provision of this Agreement shall not be construed as a waiver or limitation of that party's right to subsequently enforce and compel strict compliance with every provision of this Agreement.

 

14. APPLICABLE LAW.

 This Agreement shall be governed by the laws of the State of Virginia. 

15. INTERRUPTION OF SERVICE. 

Either party shall be excused from any delay or failure in performance required hereunder if caused by reason of any occurrence or contingency beyond its reasonable control, including, but not limited to, acts of God, acts of war, fire, insurrection, laws proclamations, edits, ordinances or regulations, strikes, lock-outs or other
 serious labor disputes, riots, earthquakes, floods, explosions or other acts of nature. The obligations and rights of the party so excused shall be extended on a day-to-day basis for the time period equal to the period of such excusable interruption. When such events have abated, the parties' respective obligations
 hereunder shall resume. In the event the interruption of the excused party's obligations continues for a

 period in excess of thirty (30) days, either party shall have the right to terminate this Agreement upon ten 
(10) days' prior written notice to the other party. 
-3-

16. ASSIGNMENT. 

Aldo Dalla-Vecchia agrees that it will not assign, sell, transfer, delegate or otherwise dispose of any rights or obligations  under this Agreement without the prior written consent of BioForce NanoSciences Holdings, Inc. Any purported assignment, transfer, or delegation shall be null and void. Nothing in this Agreement shall prevent  the consolidation of BioForce NanoSciences Holdings, Inc. with or its merger into, any other corporation, or the sale of BioForce NanoSciences Holdings, Inc. or all or substantially all of its properties or assets, or assignment by BioForce NanoSciences Holdings, Inc. this Ageement and the performance of  its obligations hereunder to any successor in interest or any affiliated Company. Subject to the foregoing, this agreement shall be binding upon and shall inure to the benefit of the parties and their respective heirs, legal representatives, successors, and permitted assigns, and shall  not benefit any person or entity other than those enumerated above. 

 

This Agreement shall be signed on behalf of BioForce NanoSciences Holdings, Inc. by Richard Kasier, Secretary and on behalf of Aldo Dalla-Vecchia by Aldo Dalla-Vecchia, Principal , RSDL RSDI Enterprises and effective as of the date first above written. 

 

This Consulting Agreement is executed and agreed to by:

/s/

____________________________

Richard Kaiser

BioForce NanoSciences Holdings, Inc.

Date: May 25, 2020

/s/

________________________

Aldo Dalla-Vecchia

RSDL Enterprises 

Date: May 25, 2020

 

-4-Converted by EDGARwiz

Exhibit 10.8

MEMORANDUM OF UNDERSTANDING

 

This Memorandum of Understanding (“MOU”), dated July 14, 2020 is by and between BioForce Nanosciences Holdings, Inc. (“BFNH”), a Nevada Corporation and Element Global, Inc., a Utah Corporation (ELGL) (BFNH and ELGL may individually referred to hereinafter as “Party” collectively referred to hereinafter as the “Parties”). This MOU sets forth the general terms and conditions for a merger, to which the BFNH and the ELGL have jointly agreed.

 

A.ELEMENT GLOBAL, INC. (ELGL) has specific assets and subsidiaries;  

 

B. ELGL (Seller) desires to sell the itself and its Assets and its subsidiaries, and BFNH (Buyer) desires to purchase all of the Assets from or controlled by ELGL, and fully take control from ELGL and its subsidiaries and conduct business activities with the  ELGL Assets

 

This MOU contemplates the proposed transaction (the “Transaction”) between the Parties that provides for BFNH to acquire all of the Assets controlled by ELGL. The general understating of the terms and conditions of the Transaction are set forth herein.

 

AGREEMENT

 

The following shall constitute an expression of the mutual intent of the Parties hereto and is contingent upon the successful negotiation, execution, and delivery of necessary documentations to hopefully proceed with a definitive agreement between BFNH and the ELGL which would set-forth in details the terms and conditions of the proposed transactions and agreements (the “Definitive Agreements”).

 

1. Understanding

 

1.1 Transaction.  BFNH desires to acquire 100% of the Assets, Company and subsidiaries that are owned by ELGL and ELGL desires to sell those Assets, Company, and subsidiaries. The Parties contemplate that the principal terms and conditions of the Transaction shall be as follows: 

 

(a) Terms:     Within 90 business days of signing this Agreement, BFNH and ELGL expects to enter into a Definitive Binding Agreement which will specifically outline the terms of the sale. 

-1-

1.2 Conditions to Consummation of the Transaction.  The obligations of BFNH, with respect to the Transaction, shall be subject to the satisfaction of the conditions customary to transactions of this type, including without limitation: (a) confirmation that the representations and warranties of ELGL are true and accurate in all respects affecting the transaction; and, (b) satisfactory completion of due diligence by BFNH.

 

1.3 Access to Relevant Documents and Properties. ELGL shall give BFNH and its representative’s full access to any personnel and all properties, documents, books, records and operations relating to the ELGL within a reasonable amount of time from the date of any such request, but in each such case within ten (10) business days from the date of request. All such requests for access under this Section shall be delivered via email to an authorized agent or via facsimile to ELGL by BFNH.

 

2.  Agreement

 

2.1 Transaction.  The undersigned agree to the terms of the Transaction as set forth above and each agree to cooperate in the negotiation, preparation of such possible Definitive Agreements, and other necessary documentation contemplated by the Transaction and agree to execute any and all documents consistent with the above terms to facilitate the consummation of such Transaction on or before Oct 13, 2020.

 

3. Costs and Expenses 

All costs and expenses incurred by BFNH or ELGL in connection with the continued negotiation of the Transaction shall be borne individually of the parties.

 

4. Exclusive Negotiating Rights

 

In order to induce Company to commit the resources, forego other potential opportunities, and incur the legal, accounting and incidental expenses necessary properly to evaluate the transaction, described above, and to negotiate the terms of, and consummate, the Transaction contemplated hereby, ELGL agrees that up to October 13, 2020, ELGL, or its affiliates and their respective officers, directors, employees and agents shall not initiate, solicit, encourage, directly or indirectly, or accept any offer or proposal, regarding the possible acquisition by any person other than BFNH, including, without limitation, by way of a purchase of shares, purchase of assets or merger, of all or any substantial part of its equity securities or assets, and shall not (other than in the ordinary course of business as heretofore conducted) provide any confidential information regarding the ELGL’s Assets or business to any person other than BFNH and its duly appointed representatives.

-2-

5. Termination

 

Termination of negotiations by Company prior to any execution and delivery of a Definitive Agreements shall be without liability and no Party hereto shall be entitled to any form of relief whatsoever, including without limitation, injunctive relief or damages. Termination by ELGL can only be made if BFNH fails to perform under this MOU and after a ten (10) day notice period has not been remedied.

 

6. Governing Law

 

This MOU shall be governed by and construed in accordance with the laws of Virginia applicable to agreements made and to be performed entirely within such State and without regard to its choice of law principles.

 

7. Confidentiality.

 

Except as provided herein, the existence and the terms of this MOU, Parties shall be maintained in confidence by the Parties hereto and their respective officers, directors and employees. Except as compelled to be disclosed by judicial or administrative process or by other requirements of law, legal process, rule or regulation (including to the extent required in connection with any filings made by the Parties or their controlling affiliates with the Securities and Exchange Commission) all public announcements, notices or other communications regarding such matters to third parties, including without limitation any disclosure regarding the transactions contemplated hereby, shall require the prior approval of all Parties hereto.

 

8. Amendment.

 

Any amendment(s) to this MOU shall be in writing and signed by all Parties hereto.

 

9. Miscellaneous.

 

9.1 Authority.  The execution, delivery and performance by ELGL of this MOU (a) has been duly authorized by all requisite corporate and, if required, stockholder action on the part of ELGL (b) and this MOU will not (i) violate (A) any provision of law, statute, rule or regulation, or of the certificate or articles of incorporation or other constitutive documents or by-laws of ELGL, (B) any order of any Governmental Authority or (C) any provision of any indenture, agreement or other instrument to which ELGL is a party or by which it or any of the Assets is or may be bound, (ii) result in the creation or imposition of any Lien upon or with respect to ELGL’s Assets,  and assets of its subsidiaries.

-3-

9.2 indemnity.

 

(a) ELGL and BFNH shall each indemnify each other, and the other Party’s directors, officers, partners, employees and agents (each such Person being called an “Indemnity”) against, and to hold each Indemnity harmless from, any and all losses, claims, damages, liabilities and related expenses, including reasonable counselfees, charges and disbursements, incurred by or asserted against any Indemnities arising out of in any way connected with, or as a result of (i) the execution or delivery of this MOU or any agreement or instrument contemplated hereby, the performance by the Parties thereto of their respective obligations hereunder or the consummation of the Definitive Agreements and the other transactions contemplated thereby, and (ii) any claim, litigation investigation or proceeding relating to any of the foregoing, whether or not any Indemnity is a party thereto.

 

(b) The provisions of this Section 9.2 shall remain operative and in full force and effect regardless of the expiration of the term of this MOU the consummation of the transactions contemplated hereby, the invalidity or unenforceability of any term or provision of this MOU, or any investigation made by or on behalf of BFNH.

 

9.3 Agreement to Perform Necessary Acts.  BFNH and ELGL agree to perform any further acts and execute and deliver any documents that may be reasonably necessary to carry out the provisions and intent of this MOU; if, not, the Section 5 above takes precedence.

 

10. Counterparts and/or Facsimile Signature.  

 

This MOU may be executed in counterparts (and by different parties hereto on different counterparts), each of which shall constitute an original but all of which when taken together shall constitute a single contract and shall become effective. Delivery of an executed signature page to this Agreement by facsimile transmission or email correspondence shall be as effective as delivery of a manually signed counterpart of this Agreement.

 

IN WITNESS WHEREOF, the Parties hereto, intending to be legally bound hereby, have each caused to be affixed hereto its or his/her hand and seal the day indicated.

 

BioForce NanoSciences Holdings, Inc.

 

/s/

____________________________

Richard Kaiser- Director/ CFO

Date July 14, 2020

 

Element Global, Inc.

 

/s/

__________________________________

Merle Ferguson-Chairman/ President

Date: July 14, 2020

 

-4-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00311-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00311-of-00352.parquet"}]]